Hill-Rom Holdings Inc. (NYSE:HRC) previous close was $111.05 while the outstanding shares total 66.37M. The firm has a beta of 0.58, a 12-month trailing P/E ratio of 27.05, and a growth ratio of 3.51. HRC’s shares traded higher over the last trading session, gaining 2.61% on 06/10/21. The shares fell to a low of $111.02 before closing at $113.95. Intraday shares traded counted 0.43 million, which was -10.81% lower than its 30-day average trading volume of 388.26K. The stock’s Relative Strength Index (RSI) is 62.56, with weekly volatility at 1.79% and ATR at 1.97. The HRC stock’s 52-week price range has touched low of $80.31 and a $117.68 high.
Investors have identified the Medical Instruments & Supplies company Hill-Rom Holdings Inc. as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $7.49 billion, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
Hill-Rom Holdings Inc. (HRC) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. For HRC, the company has in raw cash 269.7 million on their books with 102.3 million currently as liabilities. How the trend is over time is what investors should be concerned about. The company has a healthy balance sheet as their debt profile has been on a decline. In terms of their assets, the company currently has 1.28 billion total, with 793.1 million as their total liabilities.
HRC were able to record 225.7 million as free cash flow during the 07/30/2021 quarter of the year, this saw their quarterly net cash flow reduce by -26.8 million. In cash movements, the company had a total of 278.7 million as operating cash flow.
Potential earnings growth for Hill-Rom Holdings Inc. (HRC)
In order to determine the future investment potential for this stock, we will have to analyze key trends that affect it. During the 07/30/2021 quarter of the year, Hill-Rom Holdings Inc. recorded a total of 762.0 million in revenue. This figure implies that they witnessed a quarterly year/year change in their earnings with 5.09% coming in sequential stages and their sales for the 07/30/2021 quarter increasing by 2.74%.
What matters though is how it ends. When the core data for the company is broken down, then the stock sounds interesting. The company spent 354.6 million trying to sell their products during the last quarter, with the result yielding a gross income of 407.4 million. This allows shareholders to hold on to 66.37M with the recently reported earning now reading 1.31 cents per share. This is a figure that compared to analyst’s prediction for their 07/30/2021 (1.73 cents a share).
Having a look at the company’s valuation, the company is expected to record 6.36 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on HRC sounds very interesting.
Is the stock of HRC attractive?
In related news, SVP, Chief Legal Officer, Rasin Deborah sold 10,223 shares of the company’s stock in a transaction that recorded on Jun 07. The sale was performed at an average price of 110.67, for a total value of 1,131,408. As the sale deal closes, the SVP & Pres. – PSS Acute Care, Johnson Paul Sherwood now sold 11,575 shares of the company’s stock, valued at 1,285,327. Also, SVP, Pres. Front Line Care, FRANK ANDREAS G sold 5,500 shares of the company’s stock in a deal that was recorded on Oct 26. The shares were price at an average price of 91.45 per share, with a total market value of 502,975. Following this completion of acquisition, the SVP, Pres. Front Line Care, FRANK ANDREAS G now holds 5,500 shares of the company’s stock, valued at 494,450. In the last 6 months, insiders have changed their ownership in shares of company stock by 0.10%.
5 out of 7 analysts covering the stock have rated it a Buy, while 1 have maintained a Hold recommendation on Hill-Rom Holdings Inc.. 0 analysts has assigned a Sell rating on the HRC stock. The 12-month mean consensus price target for the company’s shares has been set at $129.33.